Quest Diagnostics (DGX) Free Cash Flow (2009 - 2026)

Quest Diagnostics has disclosed Free Cash Flow across 18 years of filings, most recently posting $164.0 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $164.0 million, down 16.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 25.57% YoY), and the FY2025 annual result was $1.4 billion, up 49.5% from the prior year.
• Free Cash Flow came in at $164.0 million for Q1 2026 at Quest Diagnostics, down from $307.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $455.0 million in Q4 2023 to a low of -$33.0 million in Q1 2023.
• The 5-year median for Free Cash Flow is $307.0 million (2025), against an average of $271.2 million.
• Across the five-year window, Free Cash Flow plunged 107.91% in 2023 and jumped 294.0% in 2025, its largest moves.
• Quest Diagnostics' Free Cash Flow stood at $187.0 million in 2022, then jumped by 143.32% to $455.0 million in 2023, then slipped by 25.05% to $341.0 million in 2024, then dropped by 9.97% to $307.0 million in 2025, then sank by 46.58% to $164.0 million in 2026.
• The last three Free Cash Flow figures came in at $164.0 million (Q1 2026), $307.0 million (Q4 2025), and $419.0 million (Q3 2025), per Business Quant data.